Publication | Closed Access
Azathioprine Use During Pregnancy: Unexpected Intrauterine Exposure to Metabolites
163
Citations
7
References
2006
Year
The placenta forms a (relative) barrier to AZA and its metabolites. Intrauterine exposure to 6-TGN may be minimized by careful therapeutic drug monitoring of the mother during pregnancy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1